Walgreens Boots Alliance
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001618921/000161892121000085/wba-20210831.htm
Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%).
The company is in talks to be acquired by Reliance Industries (NSE: RELIANCE) for GBP 8 billion on April 15, 2022. Previously, the company was rumored to be in talks with Kohlberg Kravis Roberts regarding a potential $55 billion public-to-private LBO as of November 5, 2019. The company has $16.8 billion of outstanding debt. Subsequently, the deal was cancelled. Also, Kohlberg Kravis Roberts sold 1.39% stake in the company (NAS: WBA) for $1.2 billion on July 28, 2016. A total of 15,000,000 shares were sold at a price of $80.55 per share. The company will not receive any proceeds from the offering.
Revenue: $135.9 B (8.80% YoY Growth)
Gross Margin: $29.9 B (22.02% margin)
Operating Margin: $4.2 B (3.10% margin)
EBITDA: $8.1 B (6.0% margin)
Net Income: $5.0 B (3.71% margin)
Enterprise Value: $76.0 B
Market Capitalization: $35.4 B
Total Debt: $37.5 B
Cash: $1.9 B
TEV/LTM Revenue: 0.56x
TEV/LTM EBITDA: 9.34x
Price/LTM Earnings: 7.03x
Operating statistics LTM as of 2/28/2022. Market data as of 6/30/2022. 10-K filed as of 10/14/2021.
Follow us on twitter at @10K_Club and hop in the Discord using the link below.